|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 11/00 | |
| A61K 31/4035 | |||
| A61K 31/443 | |||
| A61K 31/47 | |||
| A61K 45/06 |
| (11) | Number of the document | 3142748 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15727144.6 |
| Date of filing the European patent application | 2015-05-14 | |
| (97) | Date of publication of the European application | 2017-03-22 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/030764 |
| Date | 2015-05-14 |
| (87) | Number | WO 2015/175773 |
| Date | 2015-11-19 |
| (30) | Number | Date | Country code |
| 201461993467 P | 2014-05-15 | US |
| (72) |
SCHAFER, Peter, US
KORISH, Shimon, US
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | USE OF PDE4 INHIBITORS AND COMBINATIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS |
| USE OF PDE4 INHIBITORS AND COMBINATIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS |